Ray, Balmiki
Maloney, Bryan http://orcid.org/0000-0003-2364-9649
Sambamurti, Kumar
Karnati, Hanuma K.
Nelson, Peter T.
Greig, Nigel H.
Lahiri, Debomoy K. http://orcid.org/0000-0002-1664-5933
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG051086, P30AG010133)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
Article History
Received: 18 September 2019
Revised: 25 November 2019
Accepted: 19 December 2019
First Online: 3 February 2020
Change Date: 9 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41398-020-0757-2
Conflict of interest
: D.K.L. is a member of the advisory boards for Entia Biosciences, and Provaidya LLC. He also has stock options from QR Pharma for patents or patents pending on AIT-082, Memantine, Acamprosate, and GILZ analogues. All have no direct influence on the research presented here. B.R., B.M., K.S., H.K.K., P.T.N., N.H.G. have nothing to declare.
: All procedures were approved and overseen by the Institutional Biosafety. Committee (IBC), Office of Research Compliance, Indiana University, and Indianapolis, IN, USA. All experiments that used animals were reviewed and approved before initiation by the Institutional Animal Care and Use Committee (IACUC) of the Intramural Research Program, National Institute on Aging (Protocol No. 331-TGB-2021), which monitored all processes for compliance with appropriate regulatory and ethical standards.